HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N,N- dimethylenephosphonate- 1- hydroxy- 3- aminopropylidenediphosphonate

structure in first source

Also Known As:

APDDMP

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkenes: 265
      - N,N-dimethylenephosphonate-1-hydroxy-3-aminopropylidenediphosphonate: 2
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Diphosphonates: 11565
      - N,N-dimethylenephosphonate-1-hydroxy-3-aminopropylidenediphosphonate: 2

Experts

1.	Abrunhosa, Antero: 1 article (09/2004)
2.	Botelho, M Filomena: 1 article (09/2004)
3.	Dormehl, Irene C: 1 article (09/2004)
4.	Gomes, Celia: 1 article (09/2004)
5.	Jansen, David R: 1 article (09/2004)
6.	Kolar, Zvonimir I: 1 article (09/2004)
7.	Krijger, Gerard C: 1 article (09/2004)
8.	Louw, Werner K A: 1 article (09/2004)
9.	Metello, Luiz: 1 article (09/2004)
10.	Zeevaart, Jan Rijn: 1 article (09/2004)

Related Diseases

1.	Pain (Aches) 09/01/2004 - "APDDMP is synthesised from the known bone cancer pain palliation agent 1-hydroxy-3-aminopropylidenediphosphonate (APD, Pamindronate). " 01/01/2001 - "In a quest for more effective radiopharmaceuticals for pain palliation of metastatic bone cancer, this paper relates results obtained with 166Ho and 153Sm complexed to the bone seeking phosphonate, N,N-dimethylenephosphonate-1-hydroxy-4-aminopropylidenediphosphonate (APDDMP). " 01/01/2001 - "APDDMP is synthesised from the known bone cancer pain palliation agent 1-hydroxy-3-aminopropylidenediphosphonate (APD) and was complexed to lanthanide trivalent metal ions. " 09/01/2004 - "In a quest for more effective radiopharmaceuticals for pain palliation of metastatic bone cancer, this paper relates results obtained with ((117m)Sn labelled) Sn(II) complexed to the bone seeking bisphosphonate, N,N-dimethylenephosphonate-1-hydroxy-3-aminopropylidenediphosphonate (APDDMP). "
2.	Bone Neoplasms (Bone Cancer) 09/01/2004 - "APDDMP is synthesised from the known bone cancer pain palliation agent 1-hydroxy-3-aminopropylidenediphosphonate (APD, Pamindronate). " 01/01/2001 - "In a quest for more effective radiopharmaceuticals for pain palliation of metastatic bone cancer, this paper relates results obtained with 166Ho and 153Sm complexed to the bone seeking phosphonate, N,N-dimethylenephosphonate-1-hydroxy-4-aminopropylidenediphosphonate (APDDMP). " 01/01/2001 - "This work is performed to utilise the idea that the energetic beta-particle emitter, 166 Ho, coupled with phosphonate ligands such as APD and APDDMP could afford a highly effective radiopharmaceutical in the treatment of bone cancer. " 01/01/2001 - "APDDMP is synthesised from the known bone cancer pain palliation agent 1-hydroxy-3-aminopropylidenediphosphonate (APD) and was complexed to lanthanide trivalent metal ions. " 09/01/2004 - "In a quest for more effective radiopharmaceuticals for pain palliation of metastatic bone cancer, this paper relates results obtained with ((117m)Sn labelled) Sn(II) complexed to the bone seeking bisphosphonate, N,N-dimethylenephosphonate-1-hydroxy-3-aminopropylidenediphosphonate (APDDMP). "

Related Drugs and Biologics

1.	Radiopharmaceuticals
2.	N,N- dimethylenephosphonate- 1- hydroxy- 3- aminopropylidenediphosphonate
3.	Organophosphonates (Phosphonates)
4.	Lanthanoid Series Elements (Lanthanides)
5.	Metals
6.	Ligands
7.	Ions
8.	Diphosphonates (Bisphosphonates)